# Farmers & Merchants Bancshares, Inc.: financial statements, quarterly

FMFG · OTC · CIK 1698022 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmfg.md) · [Financials](/companies/fmfg/financials.md) · [Filings](/companies/fmfg/filings.md) · [Insiders](/companies/fmfg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fmfg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,815](/filings/0001437749-23-031906.md) | [3,584 d](/filings/0001437749-24-007276.md) | [3,892](/filings/0001437749-24-016592.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [467](/filings/0001437749-24-035284.md) | [355 d](/filings/0001437749-25-007333.md) | [346](/filings/0001437749-25-017235.md) | [305](/filings/0001437749-25-026658.md) | [342](/filings/0001437749-25-035228.md) | [238 d](/filings/0001437749-26-009952.md) | [316](/filings/0001437749-26-017230.md) | [280](/filings/0001437749-26-027027.md) | [462](/filings/0001437749-25-035228.md) | [549 d](/filings/0001437749-26-009952.md) | [636](/filings/0001437749-26-017230.md) | [610](/filings/0001437749-26-027027.md) |
| Net income | $k | [1,432](/filings/0001437749-24-035284.md) | [1,415 d](/filings/0001437749-25-007333.md) | [1,220](/filings/0001437749-25-017235.md) | [1,079](/filings/0001437749-25-026658.md) | [1,123](/filings/0001437749-25-035228.md) | [857 d](/filings/0001437749-26-009952.md) | [1,165](/filings/0001437749-26-017230.md) | [1,199](/filings/0001437749-26-027027.md) | [1,706](/filings/0001437749-25-035228.md) | [1,697 d](/filings/0001437749-26-009952.md) | [1,825](/filings/0001437749-26-017230.md) | [1,896](/filings/0001437749-26-027027.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001437749-24-035284.md) | not reported | [0.39](/filings/0001437749-25-017235.md) | [0.35](/filings/0001437749-25-026658.md) | [0.36](/filings/0001437749-25-035228.md) | not reported | [0.37](/filings/0001437749-26-017230.md) | [0.38](/filings/0001437749-26-027027.md) | [0.53](/filings/0001437749-25-035228.md) | not reported | [0.56](/filings/0001437749-26-017230.md) | [0.58](/filings/0001437749-26-027027.md) |
| Basic EPS | $ per share | [0.46](/filings/0001437749-24-035284.md) | not reported | [0.39](/filings/0001437749-25-017235.md) | [0.35](/filings/0001437749-25-026658.md) | [0.36](/filings/0001437749-25-035228.md) | not reported | [0.37](/filings/0001437749-26-017230.md) | [0.38](/filings/0001437749-26-027027.md) | [0.53](/filings/0001437749-25-035228.md) | not reported | [0.56](/filings/0001437749-26-017230.md) | [0.58](/filings/0001437749-26-027027.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [757](/filings/0001437749-23-031906.md) | [800](/filings/0001437749-25-007333.md) | [795](/filings/0001437749-24-016592.md) | [799](/filings/0001437749-24-026579.md) | [818](/filings/0001437749-24-035284.md) | [845](/filings/0001437749-26-009952.md) | [818](/filings/0001437749-25-017235.md) | [842](/filings/0001437749-25-026658.md) | [870](/filings/0001437749-25-035228.md) | [872](/filings/0001437749-26-027027.md) | [863](/filings/0001437749-26-017230.md) | [874](/filings/0001437749-26-027027.md) |
| Total liabilities | $m | [708](/filings/0001437749-23-031906.md) | [748](/filings/0001437749-25-007333.md) | [742](/filings/0001437749-24-016592.md) | [744](/filings/0001437749-24-026579.md) | [758](/filings/0001437749-24-035284.md) | [788](/filings/0001437749-26-009952.md) | [759](/filings/0001437749-25-017235.md) | [782](/filings/0001437749-25-026658.md) | [806](/filings/0001437749-25-035228.md) | [807](/filings/0001437749-26-027027.md) | [797](/filings/0001437749-26-017230.md) | [807](/filings/0001437749-26-027027.md) |
| Long-term debt | $m | [13.7](/filings/0001437749-23-031906.md) | [13.2](/filings/0001437749-25-007333.md) | [12.7](/filings/0001437749-24-016592.md) | [12.3](/filings/0001437749-24-026579.md) | [11.8](/filings/0001437749-24-035284.md) | [11.3](/filings/0001437749-26-009952.md) | [10.9](/filings/0001437749-25-017235.md) | [10.4](/filings/0001437749-25-026658.md) | [12.0](/filings/0001437749-25-035228.md) | [12.0](/filings/0001437749-26-027027.md) | [12.0](/filings/0001437749-26-017230.md) | [12.1](/filings/0001437749-26-027027.md) |
| Shareholders' equity | $m | [48.3](/filings/0001437749-24-035284.md) | [52.2](/filings/0001437749-26-009952.md) | [53.1](/filings/0001437749-25-026658.md) | [54.5](/filings/0001437749-25-035228.md) | [59.2](/filings/0001437749-25-035228.md) | [56.3](/filings/0001437749-26-027027.md) | [58.5](/filings/0001437749-26-027027.md) | [60.2](/filings/0001437749-26-027027.md) | [63.2](/filings/0001437749-25-035228.md) | [64.7](/filings/0001437749-26-027027.md) | [66.1](/filings/0001437749-26-027027.md) | [67.6](/filings/0001437749-26-027027.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,780 d](/filings/0001437749-24-035284.md) | [820 d](/filings/0001437749-25-007333.md) | [484](/filings/0001437749-25-017235.md) | [1,443 d](/filings/0001437749-25-026658.md) | [521 d](/filings/0001437749-25-035228.md) | [(141) d](/filings/0001437749-26-009952.md) | [590](/filings/0001437749-26-017230.md) | [1,307 d](/filings/0001437749-26-027027.md) | [2,836 d](/filings/0001437749-25-035228.md) | [1,317 d](/filings/0001437749-26-009952.md) | [1,954](/filings/0001437749-26-017230.md) | [1,590 d](/filings/0001437749-26-027027.md) |
| Capital expenditure | $k | [154 d](/filings/0001437749-24-035284.md) | [606 d](/filings/0001437749-25-007333.md) | [817](/filings/0001437749-25-017235.md) | [315 d](/filings/0001437749-25-026658.md) | [147 d](/filings/0001437749-25-035228.md) | [60.0 d](/filings/0001437749-26-009952.md) | [106](/filings/0001437749-26-017230.md) | [100 d](/filings/0001437749-26-027027.md) | [99.0 d](/filings/0001437749-25-035228.md) | [65.0 d](/filings/0001437749-26-009952.md) | [44.0](/filings/0001437749-26-017230.md) | [89.0 d](/filings/0001437749-26-027027.md) |
| Dividends paid | $k | [0.0 d](/filings/0001437749-24-035284.md) | [606 d](/filings/0001437749-25-007333.md) | [0.0](/filings/0001437749-24-016592.md) | [603 d](/filings/0001437749-25-026658.md) | [0.0 d](/filings/0001437749-25-035228.md) | [774 d](/filings/0001437749-26-009952.md) | not reported | not reported | [665 d](/filings/0001437749-25-035228.md) | [664 d](/filings/0001437749-26-009952.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,071](/filings/0001437749-24-016592.md) | [3,073](/filings/0001437749-24-026579.md) | [3,091](/filings/0001437749-24-035284.md) | [3,117](/filings/0001437749-25-017235.md) | [3,121](/filings/0001437749-25-026658.md) | [3,145](/filings/0001437749-25-035228.md) | [3,173](/filings/0001437749-26-017230.md) | [3,176](/filings/0001437749-26-027027.md) | [3,195](/filings/0001437749-25-035228.md) | [3,235](/filings/0001437749-26-017230.md) | [3,239](/filings/0001437749-26-027027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,262,958 at 2026-08-11, from the cover of the [10-Q filed 2026-08-11](/filings/0001437749-26-027027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.